0001628280-26-012545
SEC filingAlignment Healthcare achieved near-breakeven net loss and operating profitability in 2025, driven by 25% membership growth and MBR improvement to 87.5%.
Alignment Healthcare, Inc. describes itself as a next-generation, consumer-centric, clinically focused platform designed to improve the healthcare experience for seniors enrolled in Medicare Advantage. The company was founded in 2013 and is headquartered in Orange, California. Its mission is to "improve healthcare, one senior at a time." Alignment contracts directly with the Centers for Medicare & Medicaid Services (CMS) to offer Medicare Advantage plans, receiving capitated fixed monthly payments per member. As of December 31, 2025, the company had 236,300 Health Plan Membership, representing a 30% compound annual growth rate since inception. The company operates in 45 markets across California, North Carolina, Nevada, Arizona, and Texas.
The filing does not disclose separate reporting segments. The company operates as a single segment providing Medicare Advantage plans (HMO and PPO) under the Alignment Health Plan brand. All revenue is derived from CMS payments for these plans.
Alignment's key platforms include AVA, a proprietary technology platform that ingests data from over 200 sources to provide real-time, actionable insights to care teams and providers. AVA powers member portals, mobile apps, and broker tools. The Care Anywhere program is a clinician-driven care model staffed by Alignment-employed physicians, advanced practice clinicians, and other specialists that provides proactive, coordinated care to high-risk members. Other products include supplemental benefits such as dental, vision, gym access, and non-emergency transportation.
Alignment distributes its Medicare Advantage plans through brokers, an internal sales team, and digital tools like the AVA Broker Portal. Members enroll for one-year renewable terms. The company does not disclose any single customer concentration; its customers are individual Medicare-eligible seniors. The company emphasizes its "virtuous cycle" where cost savings from improved care are reinvested into richer benefits to attract and retain members.
The U.S. healthcare insurance industry is highly competitive. Alignment faces competition from other managed care companies, national insurance companies, HMOs, and PPOs, many of which have larger membership and financial resources. Barriers to entry are described as not substantial. Key competitive factors include premium price, CMS Star Ratings, breadth of benefits, network access, member engagement, care quality, and cost control.
Alignment's strategy is built around its "virtuous cycle" and a differentiated approach to Medicare Advantage as a care management business. Key strategic pillars include: insourcing clinical care through Care Anywhere to proactively manage chronic conditions and reduce hospitalizations; leveraging AVA's predictive algorithms to identify and intervene with high-risk members; aligning incentives across members, providers, brokers, and CMS; and reinvesting medical cost savings into richer benefits to drive membership growth and margin discipline.
As of December 31, 2025, Alignment employed 1,849 full-time employees, with additional seasonal staff for the Medicare Annual Enrollment Period. Clinical employees comprise approximately 25% of the workforce (over 450). The workforce is 74% female and 70% ethnically diverse; the executive team is 22% ethnically diverse and 11% female. The board of directors is 44% female and 22% ethnically diverse. The company emphasizes a hybrid-remote work model and invests in training and development.
Alignment Healthcare's MD&A reveals a transformative year in 2025, with the company transitioning from a net loss of $128.1 million to a near-breakeven net loss of $1.0 million. Revenue soared 46.1% to $3.95 billion, driven primarily by a 25% increase in health plan membership to 236,300 members and higher per-member revenue from CMS benchmark rate increases and Part D changes under the Inflation Reduction Act. The Medical Benefits Ratio (MBR) improved 1.3 percentage points to 87.5%, as medical expenses grew 43.8%—slower than revenue—due to a favorable membership mix with fewer new members relative to returning members in 2025. Operating income turned positive to $14.8 million from a loss of $101.6 million in 2024, reflecting strong operating leverage. Selling, general, and administrative expenses increased 19.4% but declined as a percentage of revenue from 13.7% to 11.2%, indicating economies of scale. Adjusted EBITDA improved dramatically from $1.3 million to $109.9 million, underscoring underlying profitability.
The company operates as a single reporting segment: providing healthcare services to seniors through Medicare Advantage plans. All revenue and expenses are generated from this unified business. Segment performance mirrors the company-wide results: membership growth in existing and new markets (45 markets across 5 states) drove top-line expansion, while clinical model improvements and a higher proportion of returning members improved margin profiles. The company emphasizes its ability to lower MBR for returning cohorts, positioning it for sustainable long-term profitability.
Management's outlook focuses on continued organic growth through market share gains in existing markets (currently only 6% market share) and disciplined expansion into new markets with large senior populations. Key strategic priorities include investing in the AVA technology platform, expanding the Care Anywhere clinical model, and potentially pursuing acquisitions of healthcare delivery groups or provider-sponsored Medicare Advantage plans. The company expects selling, general, and administrative expenses to increase in absolute dollars to support growth but anticipates further operating leverage as membership scales. No specific numeric guidance is provided, but management believes existing liquidity ($604.2 million in cash and investments) is sufficient for at least the next 12 months. Risks include regulatory changes, competitive dynamics, and the impact of seasonality on quarterly results.
As of December 31, 2025, Alignment Healthcare held $575.8M in cash and cash equivalents and $28.4M in short-term U.S. Treasury investments, providing strong liquidity. Total assets were $1,065.8M. The company's only debt is $330M in 4.25% convertible senior notes due 2029, recorded net of issuance costs at $323.2M. Shareholders' equity stood at $179.3M, up from $100.9M a year earlier, primarily due to stock option exercises and equity-based compensation.
The company disclosed purchase obligations totaling $48.4M, with $14.3M due in 2026, $26.6M in 2027-2028, and $7.6M thereafter. These include fixed minimum payments under legally enforceable service agreements. Additionally, the company has operating lease commitments of $10.0M (undiscounted) and finance lease commitments of $0.3M. Medical expenses payable, a key liability, was $474.6M, reflecting estimates for incurred but not paid claims and risk-sharing arrangements.
No share buybacks or dividends were executed or authorized during the period. Capital expenditures totaled $26.8M (0.7% of revenue), primarily for software development and equipment. The company's debt capital structure is limited to the convertible notes; no new borrowings occurred in 2025. Post-year-end, the company entered into a $200M revolving credit facility (February 2026) but had not drawn on it.
The company operates as a single reportable segment: Medicare Advantage Plans. The CODM uses consolidated net loss to assess performance and allocate resources. Segment-level revenue was $3,948.7M in 2025, with key expenses disclosed: medical expenses (less depreciation and equity-based compensation) of $3,453.9M and SG&A (less equity-based compensation) of $387.5M. All assets are located in the United States.
The most prominent risk is Alignment Healthcare's history of net losses and accumulated deficit ($1.009B). The company expects costs to rise as it scales membership, expands geographies, and invests in technology. Its growth strategy depends on attracting and retaining members in a competitive Medicare Advantage market, where enrollment is concentrated in annual periods. Any failure to price products accurately or estimate medical costs (due to utilization spikes, inflation, or new treatments) would directly impact profitability. Geographic concentration in California (84% of members) amplifies exposure to local economic, regulatory, and catastrophic events.
Substantially all revenue comes from CMS Medicare Advantage contracts. Key regulatory risks include: annual contract renewal uncertainty, potential funding cuts (sequestration, rate adjustments), and evolving program rules. The Star rating system is critical—currently 100% of members are in 4+ Star plans, but CMS methodology changes (e.g., removal of outlier adjustments, proposed 2027 revisions) could lower ratings, reducing revenue and enrollment. Risk-adjustment data validation (RADV) audits create liability from potential overpayment recoupment, especially after the vacatur of the 2023 final rule allowing extrapolation. The False Claims Act exposure is significant, with per-claim penalties up to $28,619. The Inflation Reduction Act changes to Part D (e.g., $2,100 out-of-pocket cap in 2026) increase financial responsibility for drug costs.
Cybersecurity breaches of sensitive PHI/PII could result in substantial liability, remediation costs, and reputational damage. The AVA platform, which uses AI and machine learning, introduces unique risks: inaccurate outputs affecting clinical decisions, coding, or risk adjustment; regulatory scrutiny from evolving AI governance (e.g., HHS and CMS policies). Disruptions to disaster recovery systems or third-party vendors could impair operations and member care.
Alignment competes with well-capitalized national insurers (UnitedHealth, Humana, Aetna) and traditional Medicare. Competition centers on pricing, provider networks, benefits, and Star ratings. The company's reliance on key contracts with large IPAs and hospitals creates renegotiation risk. A shortage of physicians and nurses could increase labor costs, which are difficult to pass through due to fixed premium payments.
The company faces potential lawsuits under the FCA, securities laws, intellectual property disputes, and class actions. Government audits and investigations are common in the industry and could result in fines, exclusion from programs, or changes in business practices.
The provided excerpt from the 10-K filing for Alignment Healthcare, Inc. does not contain the actual cash flow statement figures. Therefore, no analysis can be performed.